Joseph Talamo
Director of Finance/CFO bei INTENSITY THERAPEUTICS, INC.
Profil
Joseph Talamo is currently the Chief Financial Officer at Intensity Therapeutics, Inc. since 2023.
He is also currently serving as the Treasurer at Stem For Life Foundation since 2012 and at The Cura Foundation since 2013.
Previously, he held the position of Vice President & Controller at OSI Pharmaceuticals, Inc. from 2006 to 2010.
From 2011 to 2020, he worked at Caladrius Biosciences, Inc. as the CFO, Chief Accounting Officer, SVP & Controller.
He also served as the Treasurer at OSI Pharmaceuticals Foundation, Inc. from 2008 to 2010.
In 2020, he joined Hibercell, Inc. as the Chief Financial Officer & Senior Vice President until 2023.
Mr. Talamo obtained his undergraduate degree from Hofstra University in 1991 and his MBA in 1999 from the same institution.
Aktive Positionen von Joseph Talamo
| Unternehmen | Position | Beginn |
|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Director of Finance/CFO | 11.12.2023 |
| Stem For Life Foundation | Treasurer | 01.01.2012 |
| The Cura Foundation | Treasurer | 01.01.2013 |
Ehemalige bekannte Positionen von Joseph Talamo
| Unternehmen | Position | Ende |
|---|---|---|
Hibercell, Inc.
 Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Director of Finance/CFO | 01.11.2023 |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Director of Finance/CFO | 21.08.2020 |
| OSI Pharmaceuticals Foundation, Inc. | Treasurer | 01.01.2010 |
| OSI PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.01.2010 |
Ausbildung von Joseph Talamo
| Hofstra University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
| OSI Pharmaceuticals Foundation, Inc. | Miscellaneous |
| Stem For Life Foundation | |
| The Cura Foundation | |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Commercial Services |
